Search Results - "Barnardo, Martin"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma by AIT-TAHAR, Kamel, BARNARDO, Martin C. N, PULFORD, Karen

    Published in Cancer research (Chicago, Ill.) (01-03-2007)
    “…We have previously shown both humoral and CTL responses to anaplastic lymphoma kinase (ALK) in patients with ALK-positive anaplastic large-cell lymphoma…”
    Get full text
    Journal Article
  5. 5

    Role of Anti-Vimentin Antibodies in Renal Transplantation by Besarani, Dler, Cerundolo, Lucia, Smith, John D, Procter, Jeanette, Barnardo, Martin C N, Roberts, Ian S D, Friend, Peter J, Rose, Marlene L, Fuggle, Susan V

    Published in Transplantation (15-07-2014)
    “…BACKGROUNDThe role of non-HLA antibodies in rejection is not clear. We investigate whether antibodies to vimentin are made after renal transplantation and if…”
    Get full text
    Journal Article
  6. 6

    High resolution HLA haplotyping by imputation for a British population bioresource by Neville, Matt J, Lee, Wanseon, Humburg, Peter, Wong, Daniel, Barnardo, Martin, Karpe, Fredrik, Knight, Julian C

    Published in Human immunology (01-03-2017)
    “…Abstract This study aimed to establish the occurrence and frequency of HLA alleles and haplotypes for a healthy British Caucasian population bioresource from…”
    Get full text
    Journal Article
  7. 7

    CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients by Lin, Xiaorong, Gudgeon, Nancy H., Hui, Edwin P., Jia, Hui, Qun, Xue, Taylor, Graham S., Barnardo, Martin C. N. M., Lin, C. Kit, Rickinson, Alan B., Chan, Anthony T. C.

    Published in Cancer Immunology, Immunotherapy (01-07-2008)
    “…Nasopharyngeal carcinoma (NPC), an Epstein–Barr virus (EBV)-associated tumour common in Southern Chinese populations, is a potentially important target for T…”
    Get full text
    Journal Article
  8. 8

    The pharmacogenetics of methotrexate in inflammatory bowel disease by Herrlinger, Klaus R, Cummings, J.R Fraser, Barnardo, Martin C.N.M, Schwab, Matthias, Ahmad, Tariq, Jewell, Derek P

    Published in Pharmacogenetics and genomics (01-10-2005)
    “…OBJECTIVESMethotrexate (MTX) is an effective immunosuppressive treatment in inflammatory bowel disease (IBD) but its use is limited by unpredictable toxicity…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium by Chao, Michael J., Barnardo, Martin C.N.M., Lui, Guang-zhi, Lincoln, Matthew R., Ramagopalan, Sreeram V., Herrera, Blanca M., Dyment, David A., Sadovnick, A. Dessa, Ebers, George C.

    Published in Human molecular genetics (15-08-2007)
    “…The human major histocompatibility complex (MHC) class II region is associated with genetic susceptibility to multiple sclerosis (MS). Roles for HLA class I…”
    Get full text
    Journal Article
  11. 11

    Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity? by Lehmann, Donald J, Barnardo, Martin C N M, Fuggle, Susan, Quiroga, Isabel, Sutherland, Andrew, Warden, Donald R, Barnetson, Lin, Horton, Roger, Beck, Stephan, Smith, A David

    Published in Journal of neuroinflammation (18-12-2006)
    “…There are reasons to expect an association with Alzheimer's disease (AD) within the HLA region. The HLA-B & C genes have, however, been relatively…”
    Get full text
    Journal Article
  12. 12

    C4d deposition in early renal allograft protocol biopsies by KOO, Dicken D. H, ROBERTS, Ian S. D, FUGGLE, Susan V, QUIROGA, Isabel, PROCTER, Jeanette, BARNARDO, Martin C. N. M, SUTTON, Margaret, CERUNDOLO, Lucia, DAVIES, David R, FRIEND, Peter J, MORRIS, Peter J

    Published in Transplantation (15-08-2004)
    “…Deposition of the complement protein C4d in renal allograft biopsies obtained during graft dysfunction and rejection has been proposed to be a sensitive marker…”
    Get full text
    Journal Article
  13. 13

    Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients by Pulford, Karen, Hatton, Chris S. R., Collins, Graham P., Barnardo, Martin, Anderson, Amanda P., Ait-Tahar, Kamel, Banham, Alison H.

    Published in Advances in hematology (2017)
    “…Improved therapies are urgently needed for patients with diffuse large B cell lymphoma (DLBCL). Success using immune checkpoint inhibitors and chimeric antigen…”
    Get full text
    Journal Article
  14. 14
  15. 15

    CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma by Ait-Tahar, Kamel, Liggins, Amanda P, Collins, Graham P, Campbell, Andrew, Barnardo, Martin, Cabes, Maite, Lawrie, Charles H, Moir, Donald, Hatton, Chris, Banham, Alison H, Pulford, Karen

    Published in Haematologica (Roma) (01-01-2011)
    “…Vaccine development targeting the novel immunogenic Per ARNT Sim Domain containing 1 (PASD1) cancer testis antigen represents an attractive therapeutic…”
    Get full text
    Journal Article
  16. 16

    Is there MHC class II restriction of the response to MHC class I in transplant patients? by PAPASSAVAS, Andreas C, BARNARDO, Martin C. N. M, BUNCE, Mike, WELSH, Kenneth I

    Published in Transplantation (27-02-2002)
    “…In this study, we evaluated distinct HLA-DRB1 alleles to determine class II restriction of the production of HLA-A2-specific antibodies in renal transplant…”
    Get full text
    Journal Article
  17. 17

    Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients by Carr, Edward J, Wu, Mary, Harvey, Ruth, Wall, Emma C, Kelly, Gavin, Hussain, Saira, Howell, Michael, Kassiotis, George, Swanton, Charles, Gandhi, Sonia, Bauer, David LV, Adenwalla, Sherna F, Bird, Paul, Holmes, Christopher, Hull, Katherine L, March, Daniel S, Selvaskandan, Haresh, Silva, Jorge J, Tang, Julian W, Hester, Joanna, Issa, Fadi, Barnardo, Martin, Friend, Peter J, Davenport, Andrew, Goodlad, Catriona, Gopalan, Vignesh, Tangwonglert, Theerasak, Stauss, Hans J, Richter, Alex G, Cunningham, Adam F, Perez-Toledo, Marisol, Banham, Gemma D, Wall, Nadya, Clarke, Candice L, Prendecki, Maria, Clayton, Bobbi, Namjou, Sina, Silva, Vanessa, Poulten, Meghan, Bawumia, Philip, Miah, Murad, Sade, Samuel, Miranda, Mauro, Taylor, Tom, D'Angelo, Ilenia, Cabrera Jarana, Mercedes, Rahman, Mahbubur, Abreu, Janet, Sandhar, Sandeep, Bailey, Neil, Caidan, Simon, Caulfield, Marie, Wu, Mary, Harvey, Ruth, Adams, Lorin, Kavanagh, Caitlin, Warchal, Scott, Sawyer, Chelsea, Gavrielides, Mike, Kandasamy, Jag, Ambrose, Karen, Strange, Amy, Abiola, Titilayo, O'Reilly, Nicola, Hobson, Philip, Agau-Doce, Ana, Russell, Emma, Riddell, Andrew, Kjaer, Svend, Borg, Annabel, Roustan, Chloë, Billany, Roseanne E, Graham-Brown, Matthew PM, Beckett, Joseph, Bull, Katherine, Shankar, Sushma, Henderson, Scott, Motallebzadeh, Reza, Salama, Alan D, Harper, Lorraine, Mark, Patrick B, McAdoo, Stephen, Willicombe, Michelle, Beale, Rupert

    Published in The Lancet (British edition) (18-09-2021)
    “…[...]the subunit hepatitis B vaccine had to be re-formulated for this patient group to deliver a higher antigenic dose.3 There is uncertainty whether an mRNA…”
    Get full text
    Journal Article
  18. 18

    Guidance for laboratories performing molecular pathology for cancer patients by Cree, Ian A, Deans, Zandra, Ligtenberg, Marjolijn J L, Normanno, Nicola, Edsjö, Anders, Rouleau, Etienne, Solé, Francesc, Thunnissen, Erik, Timens, Wim, Schuuring, Ed, Dequeker, Elisabeth, Murray, Samuel, Dietel, Manfred, Groenen, Patricia, Van Krieken, J Han

    Published in Journal of clinical pathology (01-11-2014)
    “…Molecular testing is becoming an important part of the diagnosis of any patient with cancer. The challenge to laboratories is to meet this need, using reliable…”
    Get more information
    Journal Article
  19. 19
  20. 20